Hillary D Lum1,2, Carolyn Horney3, David Koets4, Jean S Kutner3, Daniel D Matlock3,2. 1. University of Colorado School of Medicine, Department of Medicine, Aurora, CO, USA hillary.lum@ucdenver.edu. 2. Veterans Affairs Eastern Colorado Health Care System, Denver, CO, USA. 3. University of Colorado School of Medicine, Department of Medicine, Aurora, CO, USA. 4. The Denver Hospice, Denver, CO, USA.
Abstract
BACKGROUND: Availability of cardiac medications in hospice for acute symptom management of heart failure is unknown. This study explored hospice approaches to cardiac medications for patients with heart failure. METHODS: Descriptive study using a quantitative survey of 46 US hospice agencies and clinician interviews. RESULTS: Of 31 hospices that provided standard home medication kits for acute symptom management, only 1 provided medication with cardiac indications (oral furosemide). Only 22% of the hospice agencies had a specific cardiac medication kit. Just over half (57%) of the agencies could provide intravenous inotropic therapy, often in multiple hospice settings. Clinicians described an individualized approach to cardiac medications for patients with heart failure. CONCLUSION: This study highlights opportunities for practice guidelines that inform medical therapy for hospice patients with heart failure.
BACKGROUND: Availability of cardiac medications in hospice for acute symptom management of heart failure is unknown. This study explored hospice approaches to cardiac medications for patients with heart failure. METHODS: Descriptive study using a quantitative survey of 46 US hospice agencies and clinician interviews. RESULTS: Of 31 hospices that provided standard home medication kits for acute symptom management, only 1 provided medication with cardiac indications (oral furosemide). Only 22% of the hospice agencies had a specific cardiac medication kit. Just over half (57%) of the agencies could provide intravenous inotropic therapy, often in multiple hospice settings. Clinicians described an individualized approach to cardiac medications for patients with heart failure. CONCLUSION: This study highlights opportunities for practice guidelines that inform medical therapy for hospice patients with heart failure.
Authors: Kathleen T Unroe; Melissa A Greiner; Adrian F Hernandez; David J Whellan; Padma Kaul; Kevin A Schulman; Eric D Peterson; Lesley H Curtis Journal: Arch Intern Med Date: 2010-10-11
Authors: Donald Lloyd-Jones; Robert Adams; Mercedes Carnethon; Giovanni De Simone; T Bruce Ferguson; Katherine Flegal; Earl Ford; Karen Furie; Alan Go; Kurt Greenlund; Nancy Haase; Susan Hailpern; Michael Ho; Virginia Howard; Brett Kissela; Steven Kittner; Daniel Lackland; Lynda Lisabeth; Ariane Marelli; Mary McDermott; James Meigs; Dariush Mozaffarian; Graham Nichol; Christopher O'Donnell; Veronique Roger; Wayne Rosamond; Ralph Sacco; Paul Sorlie; Randall Stafford; Julia Steinberger; Thomas Thom; Sylvia Wasserthiel-Smoller; Nathan Wong; Judith Wylie-Rosett; Yuling Hong Journal: Circulation Date: 2008-12-15 Impact factor: 29.690
Authors: Lesley H Curtis; David J Whellan; Bradley G Hammill; Adrian F Hernandez; Kevin J Anstrom; Alisa M Shea; Kevin A Schulman Journal: Arch Intern Med Date: 2008-02-25
Authors: Tiana Nizamic; M Hassan Murad; Larry A Allen; Colleen K McIlvennan; Sara E Wordingham; Daniel D Matlock; Shannon M Dunlay Journal: JACC Heart Fail Date: 2018-07-11 Impact factor: 12.035